Header Logo

Connection

KEVIN FISHER to Leukemia, Myelomonocytic, Juvenile

Back to Details
This is a "connection" page, showing publications KEVIN FISHER has written about Leukemia, Myelomonocytic, Juvenile.
KEVIN FISHER
Connection Strength
0.163
Leukemia, Myelomonocytic, Juvenile
  1. Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2019 10; 66(10):e27905.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.